Microbiome dysbiosis in lung cancer: from composition to therapy

Abstract The correlations between microbiota dysbiosis and cancer have gained extensive attention and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a great threat to human health. The healthy human lungs are consistently exposed to external environment and harbor a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ning-Ning Liu, Qiang Ma, Yang Ge, Cheng-Xiang Yi, Lu-Qi Wei, Jing-Cong Tan, Qiao Chu, Jing-Quan Li, Peng Zhang, Hui Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Acceso en línea:https://doaj.org/article/e4f4d1a8db154fe3bbc82672755c4f4c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e4f4d1a8db154fe3bbc82672755c4f4c
record_format dspace
spelling oai:doaj.org-article:e4f4d1a8db154fe3bbc82672755c4f4c2021-12-02T14:22:18ZMicrobiome dysbiosis in lung cancer: from composition to therapy10.1038/s41698-020-00138-z2397-768Xhttps://doaj.org/article/e4f4d1a8db154fe3bbc82672755c4f4c2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41698-020-00138-zhttps://doaj.org/toc/2397-768XAbstract The correlations between microbiota dysbiosis and cancer have gained extensive attention and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a great threat to human health. The healthy human lungs are consistently exposed to external environment and harbor a specific pattern of microbiota, sharing many key pathological and physiological characteristics with the intestinal tract. Although previous findings uncovered the critical roles of microbiota in tumorigenesis and response to anticancer therapy, most of them were focused on the intestinal microbiota rather than lung microbiota. Notably, the considerable functions of microbiota in maintaining lung homeostasis should not be neglected as the microbiome dysbiosis may promote tumor development and progression through production of cytokines and toxins and multiple other pathways. Despite the fact that increasing studies have revealed the effect of microbiome on the induction of lung cancer and different disease status, the underlying mechanisms and potential therapeutic strategies remained unclear. Herein, we summarized the recent progresses about microbiome in lung cancer and further discussed the role of microbial communities in promoting lung cancer progression and the current status of therapeutic approaches targeting microbiome to alleviate and even cure lung cancer.Ning-Ning LiuQiang MaYang GeCheng-Xiang YiLu-Qi WeiJing-Cong TanQiao ChuJing-Quan LiPeng ZhangHui WangNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Precision Oncology, Vol 4, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ning-Ning Liu
Qiang Ma
Yang Ge
Cheng-Xiang Yi
Lu-Qi Wei
Jing-Cong Tan
Qiao Chu
Jing-Quan Li
Peng Zhang
Hui Wang
Microbiome dysbiosis in lung cancer: from composition to therapy
description Abstract The correlations between microbiota dysbiosis and cancer have gained extensive attention and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a great threat to human health. The healthy human lungs are consistently exposed to external environment and harbor a specific pattern of microbiota, sharing many key pathological and physiological characteristics with the intestinal tract. Although previous findings uncovered the critical roles of microbiota in tumorigenesis and response to anticancer therapy, most of them were focused on the intestinal microbiota rather than lung microbiota. Notably, the considerable functions of microbiota in maintaining lung homeostasis should not be neglected as the microbiome dysbiosis may promote tumor development and progression through production of cytokines and toxins and multiple other pathways. Despite the fact that increasing studies have revealed the effect of microbiome on the induction of lung cancer and different disease status, the underlying mechanisms and potential therapeutic strategies remained unclear. Herein, we summarized the recent progresses about microbiome in lung cancer and further discussed the role of microbial communities in promoting lung cancer progression and the current status of therapeutic approaches targeting microbiome to alleviate and even cure lung cancer.
format article
author Ning-Ning Liu
Qiang Ma
Yang Ge
Cheng-Xiang Yi
Lu-Qi Wei
Jing-Cong Tan
Qiao Chu
Jing-Quan Li
Peng Zhang
Hui Wang
author_facet Ning-Ning Liu
Qiang Ma
Yang Ge
Cheng-Xiang Yi
Lu-Qi Wei
Jing-Cong Tan
Qiao Chu
Jing-Quan Li
Peng Zhang
Hui Wang
author_sort Ning-Ning Liu
title Microbiome dysbiosis in lung cancer: from composition to therapy
title_short Microbiome dysbiosis in lung cancer: from composition to therapy
title_full Microbiome dysbiosis in lung cancer: from composition to therapy
title_fullStr Microbiome dysbiosis in lung cancer: from composition to therapy
title_full_unstemmed Microbiome dysbiosis in lung cancer: from composition to therapy
title_sort microbiome dysbiosis in lung cancer: from composition to therapy
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/e4f4d1a8db154fe3bbc82672755c4f4c
work_keys_str_mv AT ningningliu microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT qiangma microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT yangge microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT chengxiangyi microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT luqiwei microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT jingcongtan microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT qiaochu microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT jingquanli microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT pengzhang microbiomedysbiosisinlungcancerfromcompositiontotherapy
AT huiwang microbiomedysbiosisinlungcancerfromcompositiontotherapy
_version_ 1718391521831550976